Immune therapy in autism: historical experience and future directions with immunomodulatory therapy.

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Michael G Chez, Natalie Guido-Estrada

Abstract

Autism affects 1 in 110 new births, and it has no single etiology with uniform agreement. This has a significant impact on the quality of life for individuals who have been diagnosed with autism. Although autism has a spectrum quality with a shared diagnosis, it presents a uniquely different clinical appearance in each individual. Recent research of suspected immunological factors have provided more support for a probable immunological process or for processes that may play a role in the acquisition of an autistic condition. These factors include prenatal, genetic, and postnatal findings, as well as the discovery of a dysfunctional chronic pro-inflammatory state in brain tissue and cerebrospinal fluid in subsets of autistic patients. These findings offer new theories that may lead to the development of disease modification or preventative therapeutic options in the near future. This article reviews prenatal, genetic, and observed immune aspects of the autism condition that may be risk factors in the presentation of the autistic clinical phenotype. Historical immune interventions in autism are reviewed and potential new therapies and interventions are discussed.

References

Mar 1, 1977·Journal of Autism and Childhood Schizophrenia·E G Stubbs, M L Crawford
Jun 1, 1990·Immunological Investigations·R P WarrenV K Singh
May 1, 1989·Journal of Child Psychology and Psychiatry, and Allied Disciplines·S SteffenburgM Bohman
Jun 1, 1986·Journal of Autism and Developmental Disorders·R P WarrenA Foster
Apr 1, 1986·Immunological Investigations·N C Margaretten, R P Warren
Mar 15, 1988·Biological Psychiatry·R D ToddD J Cohen
Jun 1, 1988·Archives of Neurology·I OlssonC Gillberg
Aug 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·G A StefanatosE Geller
Mar 1, 1993·Brain, Behavior, and Immunity·V K SinghP Cole
Jan 1, 1995·Psychological Medicine·A BaileyM Rutter
Feb 1, 1994·Archives of Pediatrics & Adolescent Medicine·A V Plioplys
Jan 1, 1994·Neuropsychobiology·A V PlioplysE Silverman
Jan 1, 1995·Neuropsychobiology·W W DanielsA R Torres
Mar 25, 1998·Journal of Child Neurology·A V Plioplys
Oct 3, 1998·Clinical Immunology and Immunopathology·V K SinghV C Yang
Jul 27, 1999·American Journal of Human Genetics·N RischR M Myers
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R H SandlerM J Schrift
Aug 2, 2000·Journal of Child Neurology·R H SandlerH M Wexler
Jun 8, 2001·Journal of the American Academy of Child and Adolescent Psychiatry·B H KingE H Cook
Aug 8, 2001·The Journal of Clinical Psychiatry·E HollanderS Novotny
Aug 30, 2001·Psychiatric Genetics·T H WassinkS R Patil
Jul 11, 2002·Journal of Autism and Developmental Disorders·Lisa A CroenSteve Selvin
Sep 26, 2002·American Journal of Human Genetics·Joachim HallmayerNeil Risch
Aug 27, 2004·Brain : a Journal of Neurology·Saskia J M C PalmenChristoph Schmitz
Oct 19, 2004·Chemistry & Biology·Alice A McCarthy
Oct 30, 2004·The American Journal of Psychiatry·David J PoseyChristopher J McDougle
Nov 17, 2004·Annals of Neurology·Diana L VargasCarlos A Pardo
Dec 4, 2004·Seminars in Pediatric Neurology·Sarah J Spence
Dec 9, 2004·The American Journal of Clinical Nutrition·S Jill JamesJames A Neubrander
Feb 9, 2005·Archives of Pediatrics & Adolescent Medicine·Lisa A CroenJudy Van de Water
Aug 2, 2005·Epilepsy Currents·Annamaria Vezzani
Oct 15, 2005·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Quirino Cordeiro, Homero Vallada

❮ Previous
Next ❯

Citations

Apr 3, 2012·Journal of Autism and Developmental Disorders·Nicole A TetreaultJohn M Allman
Jan 1, 2011·Translational Psychiatry·J-Y JungD P Wall
Dec 5, 2002·Clinical and Experimental Dermatology·W Sterry, P Walden
Jan 1, 2011·Autism Research and Treatment·Marta Macedoni-LukšičTanja Urbančič
Jul 4, 2012·BMC Pediatrics·Asimenia AngelidouTheoharis C Theoharides
Mar 23, 2013·Annual Review of Immunology·B DiamondB T Volpe
Feb 9, 2011·Journal of Immunotoxicology·Helen V Ratajczak
Jul 26, 2011·Expert Review of Gastroenterology & Hepatology·Amy C Brown, Lewis Mehl-Madrona
Sep 3, 2013·Neuroscience·H WeiX Li
Oct 17, 2012·Molecular and Cellular Neurosciences·Amaicha Mara Depino
Sep 4, 2012·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Hongen WeiXiaohong Li
Dec 3, 2014·Immunology Letters·Jennifer Mead, Paul Ashwood
Nov 27, 2018·Autism Research : Official Journal of the International Society for Autism Research·Niamh PearsonFiona S McEwen
May 30, 2019·Psychopharmacology·Robyn P ThomChristopher J McDougle
Dec 14, 2018·Developmental Psychobiology·Atiqah AzhariGianluca Esposito
May 10, 2020·International Journal of Molecular Sciences·Luca PangrazziYuri Bozzi
Nov 17, 2020·Expert Review of Clinical Immunology·Sepideh Ebrahimi MeimandNima Rezaei
Apr 25, 2020·Jornal de pediatria·Adriana Rocha BritoMarcio Moacyr Vasconcelos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.

Autism: Treatment Targets

The absence of effective treatments for autism are due to the high clinical and genetic heterogeneity between affected individuals, restricted knowledge of the underlying pathophysiological mechanisms, and the lack of reliable diagnostic biomarkers. Identification of more homogenous biological subgroups is therefore essential for the development of novel treatments based on the molecular mechanisms underpinning autism and autism spectrum disorders. Find the latest research on autism treatment targets here.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.